PKU HealthCare Corp., Ltd. (000788) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor Management Efficiency with a low ROCE of 8.60%

The company has been able to generate a Return on Capital Employed (avg) of 8.60% signifying low profitability per unit of total capital (equity and debt)

Poor long term growth as Net Sales has grown by an annual rate of -1.76% and Operating profit at 19.16% over the last 5 years

Negative results in Mar 25

With ROE of 9.49%, it has a fair valuation with a 2.22 Price to Book Value

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CNY 3,552 Million (Small Cap)

P/E

23.00

Industry P/E

Dividend Yield

1.34%

Debt Equity

-0.31

Return on Equity

9.49%

Price to Book

2.22

Revenue and Profits:

Net Sales:

452 Million

(Quarterly Results - Jun 2025)

Net Profit:

55 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

19.94%

6 Months

23.28%

1 Year

14.63%

2 Years

5.77%

3 Years

-9.83%

4 Years

16.23%

5 Years

10.59%

PKU HealthCare Corp., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-1.76%

EBIT Growth (5y)

19.16%

EBIT to Interest (avg)

13.18

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.29

Sales to Capital Employed (avg)

1.30

Tax Ratio

19.55%

Dividend Payout Ratio

34.56%

Pledged Shares

Institutional Holding

ROCE (avg)

8.60%

ROE (avg)

4.96%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.22

EV to EBIT

17.28

EV to EBITDA

13.34

EV to Capital Employed

2.77

EV to Sales

1.53

PEG Ratio

0.45

Dividend Yield

1.34%

ROCE (Latest)

16.03%

ROE (Latest)

9.49%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bearish

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bullish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -9.52% vs -4.38% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 19.96% vs 492.21% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "452.30",
          "val2": "499.90",
          "chgp": "-9.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "78.90",
          "val2": "64.10",
          "chgp": "23.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "1.90",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "54.70",
          "val2": "45.60",
          "chgp": "19.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "145.70%",
          "val2": "102.30%",
          "chgp": "4.34%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -6.05% vs 5.58% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 210.81% vs -19.86% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,049.10",
          "val2": "2,181.10",
          "chgp": "-6.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "263.00",
          "val2": "148.20",
          "chgp": "77.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.40",
          "val2": "7.20",
          "chgp": "-38.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-41.20",
          "val2": "-18.50",
          "chgp": "-122.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "138.00",
          "val2": "44.40",
          "chgp": "210.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "103.20%",
          "val2": "45.00%",
          "chgp": "5.82%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

452.30

499.90

-9.52%

Operating Profit (PBDIT) excl Other Income

78.90

64.10

23.09%

Interest

0.00

1.90

-100.00%

Exceptional Items

0.00

Consolidate Net Profit

54.70

45.60

19.96%

Operating Profit Margin (Excl OI)

145.70%

102.30%

4.34%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is -9.52% vs -4.38% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 19.96% vs 492.21% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

2,049.10

2,181.10

-6.05%

Operating Profit (PBDIT) excl Other Income

263.00

148.20

77.46%

Interest

4.40

7.20

-38.89%

Exceptional Items

-41.20

-18.50

-122.70%

Consolidate Net Profit

138.00

44.40

210.81%

Operating Profit Margin (Excl OI)

103.20%

45.00%

5.82%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -6.05% vs 5.58% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 210.81% vs -19.86% in Dec 2023

All Annual Results

Company CV

About PKU HealthCare Corp., Ltd.

PKU HealthCare Corp., Ltd.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available